featured
2023 Top Story in Respiratory Medicine: Effectiveness of Monoclonal Antibody in the Treatment of COPD
Written by
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Bhatt SP, Rabe KF, Hanania NA, et al. Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts. N Engl J Med. 2023;389(3):205-214.
- Pavord ID, Chanez P, Criner GJ, et al. Mepolizumab for eosinophilic chronic obstructive pulmonary disease. N Engl J Med. 2017;377(17):1613-1629.
- Criner GJ, Celli BR, Brightling CE, et al. Benralizumab for the prevention of COPD exacerbations. N Engl J Med. 2019;381(11):1023-1034.
- Ejike CO, Dansfield MT, Hansel NN, et al. Chronic obstructive pulmonary disease in America’s Black population. Am J Respir Crit Care Med. 2019;200(4):423-430.